The Biden administration's eleventh hour move to expand Medicare coverage for anti-obesity drugs is likely to be popular among seniors, putting the Trump administration — which would ultimately decide whether to carry out the expansion — in the hot seat.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,